Want to see CLPT full AI Analyst Report?
CLPT Stock Chart & Stats
$27.32
-$0.35(-2.27%)
At close: 4:00 PM EST
$27.32
-$0.35(-2.27%)
Day’s Range― - ―
52-Week Range$8.27 - $30.10
Previous CloseN/A
Volume88.39K
Average Volume (3M)888.94K
Market Cap
$495.13M
Enterprise Value$532.12M
Total Cash (Recent Filing)$35.59M
Total Debt (Recent Filing)$63.59M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
Aug 11, 2026EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding29,989,563
10 Day Avg. Volume512,331
30 Day Avg. Volume888,943
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)13.82
Price to Sales (P/S)10.48
P/FCF Ratio-15.84
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue13.10
Enterprise Value/Gross Profit21.19
Enterprise Value/Ebitda-22.49
Forecast
1Y Price Target
$28.33Price Target Upside3.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.98
Revenue Forecast (FY)$53.13M
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
ClearPoint Neuro News
CLPT FAQ
What was Clearpoint Neuro, Inc.’s price range in the past 12 months?
Clearpoint Neuro, Inc. lowest stock price was $8.27 and its highest was $30.10 in the past 12 months.
What is Clearpoint Neuro, Inc.’s market cap?
Clearpoint Neuro, Inc.’s market cap is $495.13M.
When is Clearpoint Neuro, Inc.’s upcoming earnings report date?
Clearpoint Neuro, Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 26 days.
How were Clearpoint Neuro, Inc.’s earnings last quarter?
Clearpoint Neuro, Inc. released its earnings results on May 13, 2026. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.273 by -$0.047.
Is Clearpoint Neuro, Inc. overvalued?
According to Wall Street analysts Clearpoint Neuro, Inc.’s price is currently Undervalued.
Does Clearpoint Neuro, Inc. pay dividends?
Clearpoint Neuro, Inc. does not currently pay dividends.
What is Clearpoint Neuro, Inc.’s EPS estimate?
Clearpoint Neuro, Inc.’s EPS estimate is -0.29.
How many shares outstanding does Clearpoint Neuro, Inc. have?
Clearpoint Neuro, Inc. has 29,989,563 shares outstanding.
What happened to Clearpoint Neuro, Inc.’s price movement after its last earnings report?
Clearpoint Neuro, Inc. reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.273. Following the earnings report the stock price went up 4.758%.
Which hedge fund is a major shareholder of Clearpoint Neuro, Inc.?
Currently, no hedge funds are holding shares in CLPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClearPoint Neuro Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.33 (3.71% Upside)
$28.33 (3.71% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 70%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 21.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $251.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.68%
12-Months-Change
Fundamentals
Return on Equity
-140.96%
Trailing 12-Months
Asset Growth
210.66%
Trailing 12-Months
Company Description
Clearpoint Neuro, Inc.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
CLPT Stock 12 Month Forecast
Average Price Target
$28.33
▲(3.71% Upside)
Technical Analysis
Ownership Overview
3.84% Insiders
8.86% Mutual Funds
0.23% Other Institutional Investors
77.43% Public Companies and
Individual Investors